CClinicalTrials.gg
CompletedNCT05341297ParentKITUpdated Sep 13, 2023

A Transdiagnostic Internet Intervention for Parents of Children With Anxiety and Depressive Symptoms

An interventional study of ParentKIT in Emotional Problem, Anxiety and Depression, sponsored by Babes-Bolyai University. Completed at 1 site in Romania. Open to participants aged 6 Years to 14 Years. Per ClinicalTrials.gov, last updated 2023-09-13.

Sponsored by Babes-Bolyai University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
111
Allocation
Randomized
Ages
6 Years to 14 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the efficacy of a transdiagnostic, parent-led, Internet-delivered intervention in reducing child and adolescent internalizing problems.

Read the detailed description

Anxiety and depressive symptoms are common in children and adolescents. There is substantial research indicating that transdiagnostic Internet interventions are effective for adults and children with anxiety and depressive disorders; however, there is limited research on the efficacy of such programs aimed at parents of children and adolescents with anxiety and depressive symptoms. This study aims to investigate the efficacy of a transdiagnostic Internet intervention for parents of children with elevated anxiety and depressive symptoms.

02

Conditions studied

  • Emotional Problem
  • Anxiety
  • Depression
  • Psychological Distress

Browse trials for

Keywords

  • Internet intervention
  • transdiagnostic
  • parent-led intervention
  • internalizing problems
  • children
  • Rational emotive and behavioral therapy
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 111 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Babes-Bolyai University is the lead sponsor of 48 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • parent of a child/ adolescent aged 6 to 14 years
  • elevated internalizing problems
  • have Internet access

Exclusion criteria

Exclusion Criteria:

  • undergoing psychotherapy/ pharmacological treatment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
111 participants (actual)

Study arms

  • Experimental
    ParentKIT

    Transdiagnostic parent-led Internet-delivered intervention Participants in the experimental group will have access to the ParentKIT intervention. The intervention was developed based on existing Cognitive Behavioral Therapy/ Rational Emotive Behavior Therapy protocols for parents of children with internalizing problems. It consists of nine modules delivered over three weeks.

    Behavioral: ParentKIT

  • No intervention
    Waitlist

    Participants in the waitlist condition will have access to the program after 3 weeks.

Interventions

  • BehavioralParentKIT

    The intervention is structured in 9 modules through which parents learn to identify and manage their children's anxiety and depressive symptoms. The Internet intervention is guided by two psychotherapists under supervision training in Cognitive Behavioral Therapy, trained by the first author on the treatment protocol.

06

What researchers measure

Primary outcomes

  1. Change in the brief Revised Children's Anxiety and Depression Scale - parent version

    Measure of child anxiety and depressive symptoms, as reported by parents. Scores range between 0 and 33; higher scores indicate higher anxiety and depressive symptoms.

    Time frame: Baseline, 3 weeks and follow-up at 1 month after treatment termination

Secondary outcomes

  1. Change in the Patient Health Questionnaire-4

    Measure of anxiety and depressive symptoms - will be used to measure changes in parental distress. Scores range between 0 and 12. Higher scores indicate higher distress.

    Time frame: Baseline, 3 weeks and follow-up at 1 month after treatment termination

  2. Change in the Parental Self-Efficacy Scale

    Measure of parental self-efficacy in relationship to parenting practices that may decrease anxiety and depression risks for adolescents. Total scores range between and 9 and 36. Higher scores indicate higher parental self-efficacy.

    Time frame: Baseline, 3 weeks and follow-up at 1 month after treatment termination

  3. Change in the Family Accommodation Scale

    Measure of parental anxiety accommodations. Scores range between 0 and 52. Higher scores indicate higher parental anxiety accommodations.

    Time frame: Baseline, 3 weeks and follow-up at 1 month after treatment termination

  4. Satisfaction with the intervention

    Client satisfaction will be measured with Client Satisfaction Questionnaire, short form (Attkisson \& Zwick, 1982). Scores range from 8 to 32, with higher scores indicating greater satisfaction with the intervention.

    Time frame: 3 weeks after treatment initiation

07

Study locations

1 site
  • Babes-Bolyai University
    Cluj-Napoca, 400015, Romania
08

References and documents

Individual participant data

Plan to share: Yes — De-identified data will be uploaded after publication of the results.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05341297
Lead sponsor
Babes-Bolyai University
Responsible party
Costina-Ruxandra Păsărelu (Assistant professor, Babes-Bolyai University) — Principal investigator
First posted
Apr 22, 2022
Start date
Mar 1, 2022
Primary completion
Jun 30, 2023
Completion
Aug 31, 2023
Last update
Sep 13, 2023

Study contacts

Costina R Păsărelu, Ph.D
principal investigator · Babes-Bolyai University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion